companydata.dkFamilien Andresens selskab til fremme af medicinsk forskning A/S: Financial statements 2022
CVR: 39694395
Familien Andresens selskab til fremme af medicinsk forskning A/S (CVR 39694395) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -7,511,875 and a net result of DKK -4,781,247 compared with DKK -4,637,104 the year before. Equity amounted to DKK 31,083,678. The solvency ratio was 99.9%.
- Gross Profit
- -7,511,875 kr.
- Profit/Loss
- -4,781,247 kr.
- Equity
- 31,083,678 kr.
- Total Assets
- 31,108,678 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -7.5 mio. | -4.8 mio. | 31.1 mio. | 0 |
| 2021 | - | -7.5 mio. | -4.6 mio. | 35.9 mio. | 0 |
| 2020 | - | -5.5 mio. | -3 mio. | 40.5 mio. | 0 |
| 2019 | - | -5.5 mio. | -2.9 mio. | 43.5 mio. | - |
Keep an eye on Familien Andresens selskab til fremme af medicinsk forskning A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Familien Andresens selskab til fremme af medicinsk forskning A/S has published its annual report for 2021. Gross profit came to DKK -7,515,000, and the net result was DKK -4,637,104.
About Familien Andresens selskab til fremme af medicinsk forskning A/S
Familien Andresens selskab til fremme af medicinsk forskning A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 2018. The company is registered under the industry Investering for egen regning. The management consists of Jørgen Jacobsen. The company is owned by CALLIE INVEST A/S. In 2025, the company reported a gross profit of DKK -25,521,250 and a net result of DKK -19,380,900 compared with DKK -6,685,198 the year before. Equity amounted to DKK 86,296.